What role does the nitric oxide system play in BPC-157’s effects?

The Nitric Oxide System’s Role in BPC-157’s Effects

The nitric oxide (NO) system is central to BPC-157’s therapeutic effects, influencing endothelial function, angiogenesis, blood pressure, and neurotransmission [1]. BPC-157 acts as a modulator of the NO system, interacting with NO agents to enhance its effects [1].

What the AI assistants say

AI assistants collectively agree that BPC-157 interacts with the nitric oxide (NO) system, playing a significant role in its therapeutic effects. They highlight that BPC-157 acts as a modulator of the NO system, rather than a simple NO booster. It can increase endothelial NO signaling when needed, such as in tissue perfusion, angiogenesis, or endothelial migration, but can also counteract both NO deficiency states induced by L-NAME and NO excess-like states induced by L-arginine [3]. The AI assistants also emphasize that BPC-157’s interaction with the NO system is characterized by modulation of NO synthase activity and expression, enhanced NO bioavailability and signaling, and interplay with other pro-healing pathways, such as the VEGF pathway [2].

What the research actually shows

The research corroborates the AI assistants’ claims, showing that BPC-157’s interaction with the NO system contributes to its therapeutic effects in several ways [1]. Firstly, BPC-157 reduces big endothelin-1 (BET-1) serum values, which is important as endothelin is a vasoconstrictive peptide that can deteriorate cerebral perfusion [1]. This interaction with NO agents suggests that BPC-157 may help maintain appropriate blood flow and vascular health [1]. Secondly, BPC-157 is suggested to have a role in maintaining endothelium integrity [1]. The endothelium is a thin layer of cells that line the interior surface of blood vessels and lymphatic vessels, and NO is a key factor in regulating its function. By interacting with the NO system, BPC-157 may contribute to the preservation of endothelial function, which is crucial for vascular health [1]. Thirdly, BPC-157 has demonstrated a marked angiogenic effect [1]. Angiogenesis is the process through which new blood vessels form from pre-existing vessels, and NO is a well-known promoter of this process. By interacting with the NO system, BPC-157 may enhance angiogenesis, which could be beneficial in various therapeutic contexts, such as wound healing and tissue regeneration [1]. Furthermore, BPC-157 has been shown to counteract the ulcerogenic effect of NO-synthase blockade induced by L-NAME (an NO synthase inhibitor) and L-arginine (an NO precursor) [7]. This suggests that BPC-157 may modulate the effects of compounds that affect NO levels, thereby influencing blood pressure and potentially other physiological processes mediated by NO [7]. In the context of traumatic brain injury, BPC-157 has been shown to influence brain 5-HT synthesis in rats, which could be related to its interaction with the NO system, as NO is known to modulate serotonin transmission in the brain [12]. This interaction with the NO system may contribute to the neuroprotective effects of BPC-157 observed in traumatic brain injury models [12].

Bottom line: The nitric oxide system is integral to BPC-157’s effects, influencing endothelial function, angiogenesis, blood pressure, and neurotransmission, which contribute to its therapeutic effects [1].

References

  1. Beneficial effect of a novel pentadecapeptide BPC 157 on — Predrag Sikirić
  2. Gastric pentadecapeptide BPC 157 and short bowel syndrome in — Marko Sever
  3. Gastric pentadecapeptide BPC 157 as an effective therapy for — Tomislav Novinscak
  4. Nitric Oxide and the Cardiovascular System
  5. Novel cytoprotective mediator, stable gastric pentadecapeptide BPC 157. Vascular recruitment and gastrointestinal tract
  6. Pentadecapeptide BPC 157 (PL 14736) improves ligament — Tomislav Cerovecki
  7. Pentadecapeptide BPC 157 Interactions with Adrenergic and — Vjekoslav Jagic
  8. Pentadecapeptide BPC 157 reduces bleeding time and — Mirjana Stupnisek
  9. The pharmacological properties of the novel peptide BPC 157 — P Sikiric(Affiliation Department of Pharmacology, Medical
  10. Traumatic brain injury in mice and pentadecapeptide BPC 157 — Mario Tudor

Continue your research

Part of our BPC-157: Mechanisms & How It Works guide.

Related topics:

PeptideXR is an open-access research project of Morpheus Institute of Technology — an AI + bioinformatics platform company advancing precision health.